MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer
A Mobile App for Tracking Time Burden of Pancreatic Cancer Treatment: A Single-Arm Feasibility Study
Ohio State University Comprehensive Cancer Center
30 participants
Mar 10, 2026
INTERVENTIONAL
Conditions
Summary
This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.
Eligibility
Inclusion Criteria4
- Adults ≥ 18 years old
- Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
- English speaking
- Access to a smartphone (Android or iOS)
Exclusion Criteria2
- Prisoners
- Patients undergoing cancer surveillance
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Ancillary studies
Receive access to MyCap application
Ancillary studies
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07619391